Reccan does not have any partnership or collaboration with any other company or entity regarding the sale of our shares. If you are interested in purchasing shares of Reccan AB, we advise you to contact Reccan directly for information.
A breakthrough in the detection of pancreatic cancer
Our unique, easy-to-use blood test makes screening for pancreatic cancer quick, accurate, and non-invasive.
The challenges with pancreatic cancer
-
High mortality rate
Pancreatic cancer has the highest mortality rate of all major cancer forms. Every year, as many people die of pancreatic cancer as breast or colon cancer.
-
Early detection vital
This disease usually causes no symptoms early on and patients are often diagnosed late, which typically results in death within a relatively short period of time.
-
Hard to treat
Pancreatic cancer is a rapid, painful, and degrading cancer with limited treatment options.
Finding the cancer early changes the trajectory of cancer mortality.
Easy-to-use blood test delivers life-changing answers
That’s why we at Reccan have spent the last decade developing a unique way of detecting pancreatic cancer. We will soon introduce a highly accurate and easy-to-use blood test for early detection.
